References
- Hidradenitis Suppurativa Foundation, Inc., http://www.hs-foundation.org (accessed June 2010).
- Revuz JE, Canoui-Poitrine F, Wolkenstein P, Viallette C, Gabison G, Pouget F, Prevalence and factors associated with hidradenitis suppurativa: Results from two case–control studies. J Am Acad Dermatol. 2008;59(4):596–601.
- Wolkenstein P, Loundou A, Barrau K, Auquier P, Revuz J; Quality of Life Group of the French Society of Dermatology. Quality of life impairment in hidradenitis suppurativa: A study of 61 cases. J Am Acad Dermatol. 2007;56(4):621–623.
- Von der Werth JM, Jemec GB. Morbidity in patients with hidradenitis suppurativa. Br J Dermatol. 2001;144(4):809–813.
- Kurzen H, Kurokawa I, Jemec GB, Emtestam L, Sellheyer K, Giamarellos-Bourboulis EJ, What causes hidradenitis suppurativa? Exp Dermatol. 2008;17(5):455–456; discussion 457–472.
- Jemec GB, Hansen U. Histology of hidradenitis suppurativa. J Am Acad Dermatol. 1996;34(6):994–999.
- Jemec GB, Faber M, Gutschik E, Wendelboe P. The bacteriology of hidradenitis suppurativa. Dermatology. 1996;193(3):203–206.
- Lapins J, Jarstrand C, Emtestam L. Coagulase-negative staphylococci are the most common bacteria found in cultures from the deep portions of hidradenitis suppurativa lesions, as obtained by carbon dioxide laser surgery. Br J Dermatol. 1999;140(1):90–95.
- Van der Zee HH, Boer J, Prens EP, Jemec GB. The effect of combined treatment with oral clindamycin and oral rifampicin in patients with hidradenitis suppurativa. Dermatology. 2009;219(2):143–147.
- Gener G, Canoui-Poitrine F, Revuz JE, Faye O, Poli F, Gabison G, Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: A series of 116 consecutive patients. Dermatology. 2009;219(2):148–154.
- Mendonca CO, Griffiths CE. Clindamycin and rifampicin combination therapy for hidradenitis suppurativa. Br J Dermatol. 2006;154(5):977–978.
- Attanoos RL, Appleton MA, Hughes LE, Ansell ID, Douglas-Jones AG, Williams GT. Granulomatous hidradenitis suppurativa and cutaneous Crohn's disease. Histopathology. 1993;23(2):111–115.
- Van der Zee HH, van der Woude CJ, Florencia EF, Prens EP. Hidradenitis suppurativa and inflammatory bowel disease: Are they associated? Results of a pilot study. Br J Dermatol. 2010;162(1):195–197.
- Shkurupiy VA, Kozyaev MA. Structural changes in the liver parenchyma and granulomas of mice with chronic BCG granulomatosis during therapy with composition of isoniazid and dialdehyde dextran. Bull Exp Biol Med. 2008;146(6):864–867.
- Sartorius K, Emtestam L, Jemec GB, Lapins J. Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity. Br J Dermatol. 2009;161(4):831–839.